Real-life data of major and minor bleeding events with direct oral anticoagulants in the one-year follow-up period: The NOAC-TURK study.

Gedikli, Ömer; Altay, Servet; Ünlü, Serkan; Çakmak, Hüseyin; Aşkın, Lütfü; Yanık, Ahmet; Beşli, Feyzullah; Sinan, Ümit; Canpolat, UĞUR; Şahin, Mahmut; Pehlivanoğlu, Seçkin

doi:10.5152/anatoljcardiol.2021.57635

Real-life data of major and minor bleeding events with direct oral anticoagulants in the one-year follow-up period: The NOAC-TURK study.

Copy For Citation

Gedikli Ö., Altay S., Ünlü S., Çakmak H. A., Aşkın L., Yanık A., ...More

Anatolian journal of cardiology, vol.25, pp.196-204, 2021 (SCI-Expanded)

Publication Type: Article / Article
Volume: 25
Publication Date: 2021
Doi Number: 10.5152/anatoljcardiol.2021.57635
Journal Name: Anatolian journal of cardiology
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
Page Numbers: pp.196-204
Keywords: direct oral anticoagulants, major bleeding, minor bleeding, real-life data, non-valvular atrial fibrillation, EURO HEART SURVEY, ATRIAL-FIBRILLATION, WARFARIN, RISK, APIXABAN, RIVAROXABAN, MANAGEMENT, REGISTRY, STROKE
Hacettepe University Affiliated: Yes

Abstract

Objective: This study aimed to evaluate the safety of direct oral anticoagulants (DOACs) in patients with non-valvular atrial fibrillation (NVAF) during daily clinical practice.